4月30日,泰格医药发布公告称,公司回购股份方案实施期限已届满。截至当日,通过集中竞价交易方式累计回购9,806,300股,占总股本1.1337%。此举旨在优化资本结构并维护股东利益。免责声明:本文内容由开放的智能模型自动生成,仅供参考。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.